Literature DB >> 17401535

Variations in activity and inhibition with pH: the protonated amine is the substrate for monoamine oxidase, but uncharged inhibitors bind better.

T Z E Jones1, D Balsa, M Unzeta, R R Ramsay.   

Abstract

It has been accepted that, as required mechanistically, the neutral form of the amine is the substrate for monoamine oxidase, despite the amine pK (a) of above 9.5. The pH dependence of the kinetic parameters for kynuramine oxidation by purified human MAO-A and for phenylethylamine oxidation by MAO-B in granulocytes at pH values from 5 to 10 was consistent with the protonated amine being used. Deprotonation of a group of pK (a) = 7.1 in MAO-B and pK (a) = 7.5 +/- 0.1 (n = 4) in MAO-A was important for efficient catalysis. The K(i) values for two oxazolidinone inhibitors of MAO-A gave opposite pH-dependence indicating that the uncharged form of each inhibitor bound better than the charged form. Decreased pH induced a blue shift in the spectral maximum of MAO-A indicative of a more hydrophobic environment around the flavin, and also influenced the redox properties of the flavin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401535     DOI: 10.1007/s00702-007-0675-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  19 in total

1.  Monoamine oxidase. I. Specificity of some substrates and inhibitors.

Authors:  C H Williams
Journal:  Biochem Pharmacol       Date:  1974-02-01       Impact factor: 5.858

2.  The effect of pH on the kinetic parameters and mechanism of beef liver monoamine oxidase.

Authors:  S Oi; K T Yasunobu; J Westley
Journal:  Arch Biochem Biophys       Date:  1971-08       Impact factor: 4.013

3.  Human liver mitochondrial monoamine oxidase. I. Kinetic studies of model interactions.

Authors:  C M McEwen; G Sasaki; W R Lenz
Journal:  J Biol Chem       Date:  1968-10-25       Impact factor: 5.157

4.  Kinetic studies on the catalytic mechanism of liver monoamine oxidase.

Authors:  M Husain; D E Edmondson; T P Singer
Journal:  Biochemistry       Date:  1982-02-02       Impact factor: 3.162

5.  Mitochondrial monoamine oxidase. I. Purification and characterization of the bovine kidney enzyme.

Authors:  V G Erwin; L Hellerman
Journal:  J Biol Chem       Date:  1967-09-25       Impact factor: 5.157

6.  Characterization of monoamine oxidase activity present in human granulocytes and lymphocytes.

Authors:  M D Balsa; N Gómez; M Unzeta
Journal:  Biochim Biophys Acta       Date:  1989-08-18

7.  Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A.

Authors:  J R Miller; D E Edmondson
Journal:  Biochemistry       Date:  1999-10-12       Impact factor: 3.162

8.  Differences in substrate specificities of monoamine oxidase A from human liver and placenta.

Authors:  A K Tan; W Weyler; J I Salach; T P Singer
Journal:  Biochem Biophys Res Commun       Date:  1991-12-31       Impact factor: 3.575

9.  Monoamine oxidase A inhibitory potency and flavin perturbation are influenced by different aspects of pirlindole inhibitor structure.

Authors:  Robert M G Hynson; Johan Wouters; Rona R Ramsay
Journal:  Biochem Pharmacol       Date:  2003-06-01       Impact factor: 5.858

10.  The chemical mechanism of action of glucose oxidase from Aspergillus niger.

Authors:  Gerd Wohlfahrt; Svetlana Trivić; Jasmina Zeremski; Draginja Pericin; Vladimir Leskovac
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

View more
  11 in total

1.  Mechanism of Flavoprotein l-6-Hydroxynicotine Oxidase: pH and Solvent Isotope Effects and Identification of Key Active Site Residues.

Authors:  Paul F Fitzpatrick; Fatemeh Chadegani; Shengnan Zhang; Vi Dougherty
Journal:  Biochemistry       Date:  2017-01-26       Impact factor: 3.162

2.  ²H kinetic isotope effects and pH dependence of catalysis as mechanistic probes of rat monoamine oxidase A: comparisons with the human enzyme.

Authors:  Jin Wang; Dale E Edmondson
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

Review 3.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

Review 4.  90 years of monoamine oxidase: some progress and some confusion.

Authors:  Keith F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2018-04-10       Impact factor: 3.575

5.  Do MAO A and MAO B utilize the same mechanism for the C-H bond cleavage step in catalysis? Evidence suggesting differing mechanisms.

Authors:  R Orru; M Aldeco; D E Edmondson
Journal:  J Neural Transm (Vienna)       Date:  2013-02-16       Impact factor: 3.575

6.  The 'gating' residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition.

Authors:  Erika M Milczek; Claudia Binda; Stefano Rovida; Andrea Mattevi; Dale E Edmondson
Journal:  FEBS J       Date:  2011-11-03       Impact factor: 5.542

7.  Radiochemical Assay of Monoamine Oxidase Activity.

Authors:  Andrew Holt
Journal:  Methods Mol Biol       Date:  2023

8.  pH dependence of a mammalian polyamine oxidase: insights into substrate specificity and the role of lysine 315.

Authors:  Michelle Henderson Pozzi; Vijay Gawandi; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

9.  Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.

Authors:  Oscar M Bautista-Aguilera; Gerard Esteban; Mourad Chioua; Katarina Nikolic; Danica Agbaba; Ignacio Moraleda; Isabel Iriepa; Elena Soriano; Abdelouahid Samadi; Mercedes Unzeta; José Marco-Contelles
Journal:  Drug Des Devel Ther       Date:  2014-10-13       Impact factor: 4.162

10.  Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.

Authors:  Irene Pachón-Angona; Bernard Refouvelet; Rudolf Andrýs; Helène Martin; Vincent Luzet; Isabel Iriepa; Ignacio Moraleda; Daniel Diez-Iriepa; María-Jesús Oset-Gasque; José Marco-Contelles; Kamil Musilek; Lhassane Ismaili
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.